521 related articles for article (PubMed ID: 9015071)
21. Contrast enhanced CT versus integrated PET-CT in pre-operative nodal staging of non-small cell lung cancer.
Ceylan N; Doğan S; Kocaçelebi K; Savaş R; Çakan A; Çağrici U
Diagn Interv Radiol; 2012; 18(5):435-40. PubMed ID: 22374706
[TBL] [Abstract][Full Text] [Related]
22. F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
Berlangieri SU; Scott AM; Knight SR; Fitt GJ; Hennessy OF; Tochon-Danguy HJ; Clarke CP; McKay WJ
Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S25-30. PubMed ID: 10536941
[TBL] [Abstract][Full Text] [Related]
23. Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
Chin R; Ward R; Keyes JW; Choplin RH; Reed JC; Wallenhaupt S; Hudspeth AS; Haponik EF
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2090-6. PubMed ID: 8520780
[TBL] [Abstract][Full Text] [Related]
24. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
[TBL] [Abstract][Full Text] [Related]
25. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
[TBL] [Abstract][Full Text] [Related]
26. Lymph node staging in lung cancer using [18F]FDG-PET.
Halter G; Buck AK; Schirrmeister H; Aksoy E; Liewald F; Glatting G; Neumaier B; Mühling B; Nüssle-Kügele K; Hetzel M; Sunder-Plassmann L; Reske SN
Thorac Cardiovasc Surg; 2004 Apr; 52(2):96-101. PubMed ID: 15103582
[TBL] [Abstract][Full Text] [Related]
27. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
[TBL] [Abstract][Full Text] [Related]
29. Targeted lymph node biopsy in mediastinoscopy using 3D FDG-PET/CT movies: a feasibility study.
Siepel FJ; de Bruin WI; van Duyn EB; Steenvoorde P; Wagenaar NR; Slump CH; van Dalen JA
Nucl Med Commun; 2012 Apr; 33(4):439-44. PubMed ID: 22311052
[TBL] [Abstract][Full Text] [Related]
30. Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer.
Bury T; Paulus P; Dowlati A; Corhay JL; Weber T; Ghaye B; Schoffers J; Limet R; Albert A; Rigo P; Radermecker M
Eur Respir J; 1996 Dec; 9(12):2560-4. PubMed ID: 8980969
[TBL] [Abstract][Full Text] [Related]
31. Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration.
Aquino SL; Asmuth JC; Alpert NM; Halpern EF; Fischman AJ
J Comput Assist Tomogr; 2003; 27(4):479-84. PubMed ID: 12886128
[TBL] [Abstract][Full Text] [Related]
32. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography.
Sasaki M; Ichiya Y; Kuwabara Y; Akashi Y; Yoshida T; Fukumura T; Murayama S; Ishida T; Sugio K; Masuda K
Eur J Nucl Med; 1996 Jul; 23(7):741-7. PubMed ID: 8662111
[TBL] [Abstract][Full Text] [Related]
33. [Clinical value of computed tomography and fluorine-18 fluorodeoxyglucose positron remission tomography in diagnosis of mediastinal metastasis of non small cell lung cancer].
Zhi XY; Liu BD; Xu QS; Zhang Y; Su L; Wang HR; Hu M
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2026-9. PubMed ID: 16313793
[TBL] [Abstract][Full Text] [Related]
34. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.
Lasnon C; Hicks RJ; Beauregard JM; Milner A; Paciencia M; Guizard AV; Bardet S; Gervais R; Lemoel G; Zalcman G; Aide N
Clin Nucl Med; 2012 Oct; 37(10):971-6. PubMed ID: 22899197
[TBL] [Abstract][Full Text] [Related]
35. Improving diagnostic performance of
Yang DD; Mirvis E; Goldring J; Patel ARC; Wagner T
Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186
[TBL] [Abstract][Full Text] [Related]
36. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
[TBL] [Abstract][Full Text] [Related]
37. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.
Konishi J; Yamazaki K; Tsukamoto E; Tamaki N; Onodera Y; Otake T; Morikawa T; Kinoshita I; Dosaka-Akita H; Nishimura M
Respiration; 2003; 70(5):500-6. PubMed ID: 14665776
[TBL] [Abstract][Full Text] [Related]
38. Improvement of non-small-cell lung cancer staging by means of positron emission tomography.
Albes JM; Lietzenmayer R; Schott U; Schülen E; Wehrmann M; Ziemer G
Thorac Cardiovasc Surg; 1999 Feb; 47(1):42-7. PubMed ID: 10218620
[TBL] [Abstract][Full Text] [Related]
39. [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)].
Sánchez Sánchez R; Rodríguez Fernández A; Gómez Río M; Alkurdi Martínez A; Castellón Rubio VE; Ramos Font C; Sánchez-Palencia Ramos A; Delgado Pérez JR; Llamas Elvira JM
Rev Esp Med Nucl; 2011; 30(4):211-6. PubMed ID: 21514978
[TBL] [Abstract][Full Text] [Related]
40. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.
Patz EF; Lowe VJ; Goodman PC; Herndon J
Chest; 1995 Dec; 108(6):1617-21. PubMed ID: 7497771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
